Table 2 Univariable analysis of recurrence-free survival in ovarian cancer patients

Age

≥ 60

1.337

0.878–2.036

0.175

FIGO Stage

III/IV

6.215

3.760–10.271

< 0.001

Histological type

HGSC

3.602

2.320–5.592

< 0.001

T classification (pT)

2/3

6.233

3.566–10.897

< 0.001

Lymph node metastasis

(+)

2.490

1.392–4.455

0.002

Distant metastasis

(+)

4.345

2.528–7.466

< 0.001

Peritoneal dissemination

(+)

5.945

3.719–9.502

< 0.001

Ascites cytoloy

(+)

3.731

2.032–6.848

< 0.001

Type of surgery

Suboptimal

5.927

3.667–9.581

0.015

CA-125 (U/mL)

≥ 35

2.812

1.226–6.447

0.014

Platinum sensitivity

Resistance

4.893

2.935–8.159

< 0.001

Neoadjuvant chemotherapy

(+)

3.261

1.883–5.649

< 0.001

SPON1

High

3.567

2.085–6.105

< 0.001